NCT07038304View on ClinicalTrials.gov

The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)

PHASE2RecruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 3, 2025

Primary Completion Date

January 3, 2028

Study Completion Date

January 3, 2029

Conditions
Prostate Cancer (Adenocarcinoma)OligoProgressive Metastatic DiseaseCastration Resistant Metastatic Prostate CancerRadiotherapy
Interventions
RADIATION

Metastasis directed radiotherapy

According to guidelines, in the case of oligoprogression next line systemic treatment is recommended. This study investigates the potential delay of NEST and rPFS by MDRT.

Trial Locations (2)

Unknown

RECRUITING

UMC Groningen, Groningen

NOT_YET_RECRUITING

Radboud Umc, Nijmegen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER